We are live on
!
Find out more
KTC
Kistler-Tiffany Companies Portfolio holdings
AUM
$616M
1-Year Est. Return
16.74%
This Fund
S&P 500
This Quarter
Est. Return
+5.09%
1 Year Est. Return
+16.74%
3 Year Est. Return
+52%
5 Year Est. Return
+74.37%
10 Year Est. Return
+182.26%
AUM
$253M
AUM Growth
+$14M
(+5.8%)
Cap. Flow
+$2.75M
Cap. Flow
% of AUM
1.09%
Top 10 Holdings %
Top 10 Hldgs %
47.78%
Holding
598
New
29
Increased
159
Reduced
84
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$875K |
| 2 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$793K |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$735K |
| 4 |
Vanguard High Dividend Yield ETF
VYM
|
+$512K |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$475K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$1.1M |
| 2 |
Vanguard Dividend Appreciation ETF
VIG
|
+$583K |
| 3 |
ExxonMobil
XOM
|
+$418K |
| 4 |
Aon
AON
|
+$393K |
| 5 |
GE Aerospace
GE
|
+$372K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.73% |
| 2 | Consumer Staples | 5.85% |
| 3 | Financials | 5.14% |
| 4 | Technology | 4.75% |
| 5 | Industrials | 4.36% |
Similar funds
FANJ
NWM
KC
EWM
SAM
TWI
TF
ECI
Kistler-Tiffany Companies's Q4 2017 Portfolio in Review
As of Q4 2017, Kistler-Tiffany Companies held 598 positions worth $253M, up 5.8% from $239M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Kistler-Tiffany Companies's Q4 2017 filing shows 29 new, 159 increased, 84 reduced and 21 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 11,279 shares worth $745K. The largest sale was West Pharmaceutical, an estimated $1.1M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 12% a quarter earlier, followed by Consumer Staples and Financials.
- Kistler-Tiffany Companies's largest Q4 2017 buy was iShares Core MSCI EAFE ETF: 11,279 shares worth $745K.
- Kistler-Tiffany Companies added most to iShares Core S&P 500 ETF in Q4 2017, an estimated $875K increase.
- Kistler-Tiffany Companies's biggest Q4 2017 reduction was West Pharmaceutical, cutting an estimated $1.1M.
- Kistler-Tiffany Companies fully exited Aon in Q4 2017, selling an estimated $393K.
- Kistler-Tiffany Companies's ten largest holdings make up 48% of its $253M portfolio in Q4 2017.
- Kistler-Tiffany Companies opened 29 new positions and closed 21 in Q4 2017.
- Kistler-Tiffany Companies's portfolio value rose 5.8% quarter-over-quarter to $253M.
Based on Kistler-Tiffany Companies's 13F filing for Q4 2017, filed 11 Jan 2018.